The global demand for Glycobiology Market is presumed to reach the market size of nearly USD 3723.48 MN by 2028 from USD 1161.98 MN in 2021 with a CAGR of 18.1% under the study period 2022 - 2028.
Glycobiology is the branch of biology that studies the structure and function of molecules containing carbohydrates, including sugar and saccharides, also known as glycans. Glycobiology is found in various organisms. Glycobiology plays a significant role in innate immunity, cell regulatory pathways, protein interactions and folding, and cell configuration modulation. Glycobiology is a newly increasing biological field of interest for various areas such as biotechnology, biomedical, and research.
Market Dynamics
The rising prevalence of disorders like diabetes and obesity, rising healthcare spending, added by the scaling up diagnostic industry are driving the expansion of the global glycobiology market. Moreover, increasing investments in research by various government bodies and the development of novel drugs by pharmaceutical and biotechnology companies are other major factors anticipated to drive the field of glycoscience, thereby causing the overall market. Furthermore, technological advancements are expected to fuel market growth. In addition, the growing use of glycobiology in cancer research, due to the relevance of surface glycan in the metastatic and neoplastic characteristics of tumour cells, is estimated to drive market growth. However, the high cost associated with tools is expected to limit market growth to some extent during the forecast period.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of glycobiology. The growth and trends of glycobiology industry provide a holistic approach to this study.
Market Segmentation
This section of the glycobiology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product- Instruments
- Enzymes
- Consumables
- Reagent Kits
By Enzyme- Galactosidases
- GlcNAc Transferases
- Others
By Application- Drug Discovery And Development
- Diagnostic Applications
- Industrial Applications
- Therapeutic Applications
- Others
By End User- Biopharmaceutical Companies
- Research Laboratories
- Hospitals
- Diagnostic Centers
- Contract Research Organizations
- Biotechnology Industries
- Academic Institutes
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Glycobiology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Glycobiology Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the glycobiology market include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, ProZyme Inc., NEB Inc., Agilent Technologies, New England Biolabs, Takara Bio, Waters Corporation, Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
